Correction: AroCell nomination committee for the AGM 2022

03 December 2021 - 17:44

Correction: Annual general meeting on May 6, 2021.

AroCell AB (publ.) publishes the nomination committee’s composition for the AGM in 2022.

The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on May 6, 2021, consists of:
• Clas Runnberg, represents Labbex Förvaltnings AB
• Jon Eiken, represents his own shares
• Mikael Lönn, represents his own shares
The nomination committee shall, before the annual general meeting 2022, prepare a proposal for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, the election of auditors, the determination of fees, and matters pertaining thereto.
For more information, please visit:
Nomination committee - AroCell
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting 2022 can do so by e-mail to [email protected] (header ”AroCell´s nomination committee”). Proposals should be submitted to the nomination committee before January 31st, 2022.
For further information, please contact:
Anders Hultman, CEO at AroCell
Email: [email protected]
The information was submitted for publication, through the agency of the contact person set out above, at 17:44 on December 03, 2021.

Provided by: MFN
Nasdaq First North GM (Sweden)
AroCell AB
AroCell is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More